Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Tianshu PanMary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0009-0003-8202-1306
Olawale A AlimiMary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0002-0543-4962
Bo LiuMary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0003-2455-2021
Mena A KrishnanMary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Mitchell KussMary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Wei ShiMary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0009-0001-2085-0323
Jairam KrishnamurthyDivision of Oncology & Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0003-0939-4184
Jianghu James DongDepartment of Biostatistics, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Rebecca E Oberley-DeeganDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0002-0391-142X
Bin DuanMary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0002-5647-3793
Funding
Translational Imaging and Behavioral Assessment (TIBA) CoreP20GM130447 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Anna Dunaevsky · 2020 to 2026
$20.7M
Flupirtine Analogue Synthesis and Screening for the Treatment of Chemotherapy-Induced Neuropathic PainR21CA298918 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Bin Duan, Paul Trippier · 2025 to 2026
$395k
LB606 Nebraska Stem Cell Grant NANCI NIH HHS 1R21CA298918-01NCI NIH HHS R21 CA298918Nebraska Research Initiative Funding NANIGMS NIH HHS P20 GM130447University of Nebraska Medical Center UNMC Center for Drug Design and Innovation (CDDI) Seed GrantUniversity of Nebraska Medical Center UNMC Graduate Studies Fellowship
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Therapeutic Potential of BMX-001 for Preventing Chemotherapy-Induced Peripheral Neuropathic Pain. · full record | OpenQuestion